[1] Ni W, Han Y, Zhao J, et al. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections:a systematic review and meta-analysis[J]. Int J Antimicrob Agents, 2016, 47(2):107-116.
[2] 赵慧,任爽,甄健存. 替加环素致低纤维蛋白原血症回顾性分析[J]. 中国医院药学杂志, 2020, 40(23): 2464-2467.
[3] 秦琰杰,吕鹏,王运红,等. 替加环素致低纤维蛋白原血症的回顾性分析[J]. 中国医院药学杂志, 2022, 42(9): 916-920.
[4] 沈莉,方伟,张尧,等. 替加环素致严重肾功能不全患者凝血功能异常的回顾性分析[J]. 中国药房, 2023, 34(22): 2766-2769.
[5] 杨海华,周聪,沈国强,等. 134例替加环素致药物性肝损伤老年患者临床特征回顾性分析[J].. 实用肝脏病杂志, 2022, 25(3): 375-378.
[6] Shi X, Zuo C, Yu L, et al. Real-world data of tigecycline-associated drug-induced liver injury among patients in China: a 3-year retrospective study as assessed by the updated RUCAM[J]. Front Pharmacol, 2021,12:761167.
[7] Yu Z, Zhao Y, Jin J, et al. Prevalence and risk factors of tigecycline-induced liver injury: a multicenter retrospective study[J]. Int J Infect Dis, 2022,120:59-64.
[8] 王婷婷,赵宇晗,刘佩本,等. 替加环素相关性肝损伤的研究进展[J]. 医药导报, 2023, 42 (8): 1186-1191.
[9] Hakeam H A, Al Duhailib Z, Salahuddin N, et al. Impact of tigecycline versus imipenem-cilastatin on fibrinogen levels following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study[J]. J Chemother, 2018,30(4):224-232.
[10] 孙涛,杨鹏,郑瑶,等. 亚胺培南/西司他丁对1372例患者肝功能的影响[J]. 药物流行病学杂志, 2018, 27(1): 38-41.
[11] 赵莹,崔向丽,张超,等. 替加环素致凝血功能障碍药学监护一例[J]. 临床药物治疗杂志, 2021, 19(6): 87-89. |
